Deutsche Bank’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $348K | Buy |
11,864
+2,398
| +25% | +$70.3K | ﹤0.01% | 2635 |
|
2025
Q1 | $243K | Sell |
9,466
-257
| -3% | -$6.61K | ﹤0.01% | 2841 |
|
2024
Q4 | $281K | Buy |
9,723
+4,370
| +82% | +$126K | ﹤0.01% | 2911 |
|
2024
Q3 | $127K | Buy |
5,353
+60
| +1% | +$1.42K | ﹤0.01% | 3093 |
|
2024
Q2 | $91.5K | Buy |
+5,293
| New | +$91.5K | ﹤0.01% | 3111 |
|
2022
Q2 | – | Sell |
-2,363
| Closed | -$84K | – | 4157 |
|
2022
Q1 | $84K | Buy |
2,363
+955
| +68% | +$33.9K | ﹤0.01% | 3590 |
|
2021
Q4 | $123K | Buy |
1,408
+73
| +5% | +$6.38K | ﹤0.01% | 3565 |
|
2021
Q3 | $153K | Buy |
+1,335
| New | +$153K | ﹤0.01% | 3660 |
|